Hybrid Interactive Avatars for Post-COVID Sufferers

NCT06218849 | Unknown

• 1 other identifier: 16SV9183
• Study Type: observational
• Target: 130
• Locations: 1 country
• Sites: 1

Brief Summary

The goal of this observational study is to evaluate an app to improve communication and information flows for persons suffering from Post-COVID-19 syndrome (PCS). The main questions it aims to answer are:

• How can custom virtual characters (avatars) help to collect more data for the diagnosis of PCS?
• Can conversations with virtual (mobile) characters (avatars) and the presentation of health data help to improve the diagnosis and understanding of PCS?
• How should these virtual characters (avatars) be designed for people with PCS and healthcare professionals to be useful in the long term? This concerns appearance, dialog, personality and functions. Participants will be asked to use and test the app and take part in two interviews at the beginning and end of the study.

Conditions

Post-Acute COVID-19 Syndrome

Keywords

Post-COVID-19 syndrome; Avatar; App development

Outcome Measures

Primary Outcomes (1)

• Final evaluation of the application field tests

  Following the successful completion of the field test (phase 2), a full evaluation will be carried out. The overall system and its use will be evaluated, taking into account both the perspective of those affected by PCS and that of the medical staff.

  24 months after initiation of the study

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

The study will include female and male subjects who have been proven to have COVID-19 and are at least 18 years old.

You may qualify if:

• Existence of a declaration of consent
• Stable clinical condition
• Diagnosis of Post-COVID syndrome according to the World Health Organization (WHO):
• Symptoms persist for more than 12 weeks
• Duration: at least 2 months
• Etiology: no alternative diagnosis
• Progression: persistent, recurrent, fluctuating

You may not qualify if:

• Known psychiatric or somatic illness that can explain the symptoms

Sponsors & Collaborators

• University Hospital of Cologne: lead
• University of Applied Sciences Cologne: collaborator
• Humanizing Technologies GmbH: collaborator

Study Sites (1)

University Hospital Cologne

Cologne, Northrhine-Westfalia, 50937, Germany

Location

MeSH Terms

Conditions

Post-Acute COVID-19 Syndrome

Condition Hierarchy (Ancestors)

COVID-19; Pneumonia, Viral; Pneumonia; Respiratory Tract Infections; Infections; Virus Diseases; Coronavirus Infections; Coronaviridae Infections; Nidovirales Infections; RNA Virus Infections; Lung Diseases; Respiratory Tract Diseases; Post-Infectious Disorders; Chronic Disease; Disease Attributes; Pathologic Processes; Pathological Conditions, Signs and Symptoms

Central Study Contacts

Clara Lehmann, MD

CONTACT

+49221 4784433; clara.lehmann@uk-koeln.de

Cristina Polidori, MD

CONTACT

+49221 47832753; maria.polidori-nelles@uk-koeln.de

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Prof. Dr. Clara Lehmann

Study Record Dates

• First Submitted: January 22, 2024
• First Posted: January 23, 2024
• Study Start: January 1, 2024
• Primary Completion: December 1, 2025
• Study Completion: December 1, 2025
• Last Updated: January 23, 2024

Record last verified: 2024-01

Locations

DE (1)